Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: A meta-analysis of randomized trials

Journal of the American College of Cardiology

Volumn 57, Issue 5, 2011, Pages 590-600

  Messerli, Franz H ^a   Makani, Harikrishna ^a   Benjo, Alexandre ^a   Romero, Jorge ^a   Alviar, Carlos ^a   Bangalore, Sripal ^b  

^a St Luke's Roosevelt Hospital ^*  (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ambulatory blood pressure; hydrochlorothiazide; hypertension; meta analysis

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; IRBESARTAN; ISRADIPINE; LACIDIPINE; LISINOPRIL; LOSARTAN; NIFEDIPINE; PINACIDIL; QUINAPRIL; RAMIPRIL; SPIRAPRIL; TELMISARTAN; ZOFENOPRIL;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; COCHRANE LIBRARY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; EMBASE; HUMAN; HYPERTENSION; MEDLINE; META ANALYSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79251482197     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.07.053     Document Type: Article

References (53)

1. SDI/Verispan, VONA, Full year 2008 Drug topics http://www.drugtopics.com Accessed December 14, 2010
2. R.S. Stafford, L.K. Bartholomew, and W.C. Cushman Impact of the ALLHAT/JNC7 dissemination Project on thiazide-type diuretic use Arch Intern Med 170 2010 851 858
3. J. Higgins, and S. Green Assessing Risk of Bias in Included Studies Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 2008 The Cochrane Collaboration Oxford
4. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.F. Stroup Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement Quality of Reporting of Meta-Analyses Lancet 354 1999 1896 1900
5. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
6. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test Br Med J 315 1997 629 634
7. D. Follmann, P. Elliott, I. Suh, and J. Cutler Variance imputation for overviews of clinical trials with continuous response J Clin Epidemiol 45 1992 769 773
8. D.G. Altman, and J.M. Bland Interaction revisited: the difference between two estimates Br Med J 326 2003 219
9. A. Damasceno, P. Caupers, A. Rafik, A. Santos, and J. Polonia [The additional efficacy of the nifedipine-diuretic combination depends on the potency of the drug administered first and not the sequence of administration. A double blind study in salt-sensitive black hypertensives] Rev Port Cardiol 18 1999 9 19
10. C. Falconnet, M. Bochud, P. Bovet, M. Maillard, and M. Burnier Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent J Hypertens 22 2004 1213 1220
11. D. Galzerano, P. Tammaro, and A. Cerciello Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study J Hum Hypertens 18 2004 53 59
12. H. Kraiczi, J. Hedner, Y. Peker, and L. Grote Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea Am J Respir Crit Care Med 161 2000 1423 1428
13. Y. Lacourcire, and L. Poirier Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertension Am J Hypertens 16 2003 1036 1042
14. Y. Lacourcire, L. Poirier, J. Lefebvre, F. Archambault, J. Cleroux, and G. Boileau Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension Am J Hypertens 8 1995 1154 1159
15. L.H. Pelttari, E.K. Hietanen, T.T. Salo, M.J. Kataja, and I.M. Kantola Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing Am J Hypertens 11 1998 272 279
16. T. Suonsyrj, T. Hannila-Handelberg, and K.J. Paavonen Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study J Hypertens 26 2008 1250 1256
17. M.A. Tedesco, G. Ratti, and D. Aquino Effects of losartan on hypertension and left ventricular mass: a long-term study J Hum Hypertens 12 1998 505 510
18. S. Ubaid-Girioli, S.E. Ferreira-Melo, and L.A. Souza Aldosterone escape with diuretic or angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension J Clin Hypertens (Greenwich) 9 2007 770 774
19. W.B. White, J.M. Cleveland, and R.L. Rolleri Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial J Hum Hypertens 22 2008 559 568
20. L.M. Wing, L.F. Arnolda, J. Upton, and D. Molloy Candesartan and hydrochlorothiazide in isolated systolic hypertension Blood Press 12 2003 246 254
21. G. Abate, M. Zito, P. Carbonin, A. Cocchi, D. Cucinotto, and R. Manupolo Pinacidil or hydrochlorothiazide alone or in combination in the treatment of hypertension in the elderly Curr Ther Res 59 1998 62 71
22. I.V. Radevski, Z.P. Valtchanova, G.P. Candy, A.M. Wald, T. Ngcezula, and P. Sareli Comparison of indapamide and low-dose hydrochlorothiazide monotherapy in black patients with mild to moderate hypertension S Afr Med J 92 2002 532 536
23. Y. Lacourcire, and P. Provencher Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild to moderate essential hypertension Br J Clin Pharmacol 27 1989 371 376
24. T.O. Morgan, and A. Anderson Different drug classes have variable effects on blood pressure depending on the time of day Am J Hypertens 16 2003 46 50
25. C.A. Silagy, J.J. McNeil, and B.P. McGrath Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension Am J Cardiol 70 1992 1299 1305
26. M.R. Weir, E. Reisin, B. Falkner, H.G. Hutchinson, L. Sha, and M.L. Tuck Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients TROPHY Study Group Am J Hypertens 11 1998 914 920
27. L.M. Wing, L.F. Arnolda, and P.J. Harvey Lacidipine, hydrochlorothiazide and their combination in systolic hypertension in the elderly J Hypertens 15 1997 1503 1510
28. J.D. Finkielman, G.L. Schwartz, A.B. Chapman, E. Boerwinkle, and S.T. Turner Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide Am J Hypertens 18 2005 398 402
29. J. Skoularigis, V. Strugo, A. Chopamba, S. Setekge, and P. Sareli Low dose hydrochlorothiazide (12.5 to 25 mg daily) as monotherapy in black patients with mild to moderate hypertension Assessment by ambulatory blood pressure monitoring Am J Hypertens 8 1995 1046 1050
30. I.V. Radevski, Z.P. Valtchanova, G.P. Candy, M.N. Hlatswayo, and P. Sareli Antihypertensive effect of low-dose hydrochlorothiazide alone or in combination with quinapril in black patients with mild to moderate hypertension J Clin Pharmacol 40 2000 713 721
31. P. Sareli, I.V. Radevski, and Z.P. Valtchanova Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa Arch Intern Med 161 2001 965 971
32. A. Zanchetti, G. Crepaldi, and M.G. Bond Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLISa randomized double-blind trial Stroke 35 2004 2807 2812
33. Y. Lacourcire, L. Poirier, and J. Lefebvre Expedited blood pressure control with initial angiotensin II antagonist/diuretic therapy compared with stepped-care therapy in patients with ambulatory systolic hypertension Can J Cardiol 23 2007 377 382
34. Y. Lacourcire, J. Lefebvre, L. Poirier, F. Archambault, and W. Arnott Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination A randomized, double-blind, placebo-controlled, factorial-design trial Am J Hypertens 7 1994 137 145
35. R.L. Byyny, M. LoVerde, and W. Mitchell Treatment of hypertension in the elderly with a new calcium channel blocking drug, nitrendipine Am J Med 86 1989 49 55
36. M.E. Ernst, B.L. Carter, and C.J. Goerdt Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure Hypertension 47 2006 352 358
37. T.P. Hiltunen, T. Suonsyrj, and T. Hannila-Handelberg Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (the GENRES study) Am J Hypertens 20 2007 311 318
38. V. Papademetriou, J.S. Gottdiener, P. Narayan Isradipine Study Group Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial J Am Coll Cardiol 30 1997 1802 1808
39. E. Reisin, M.R. Weir, B. Falkner, H.G. Hutchinson, D.A. Anzalone, M.L. Tuck Treatment in Obese Patients With Hypertension (TROPHY) Study Group Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial Hypertension 30 1997 140 145
40. M.R. Rinder, R.J. Spina, L.R. Peterson, C.J. Koenig, C.R. Florence, and A.A. Ehsani Comparison of effects of exercise and diuretic on left ventricular geometry, mass, and insulin resistance in older hypertensive adults Am J Physiol Regul Integr Comp Physiol 287 2004 R360 R368
41. M.J. Roman, M.H. Alderman, and T.G. Pickering Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy Am J Hypertens 11 1998 387 396
42. A.L. Beitelshees, Y. Gong, and K.R. Bailey Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazide J Clin Hypertens (Greenwich) 12 2010 14 21
43. B. Heran, M. Wong, I. Heran, and J. wright Blood Pressure Lowering Efficacy of Angiotensin Converting Enzyme (ACE) Inhibitors for Primary Hypertension Cochrane Database of Systematic Reviews Issue 4 2009
44. B. Heran, M. Wong, I. Heran, and J. wright Blood Pressure Lowering Efficacy of Angiotensin Receptor Blockers for Primary Hypertension Cochrane Database of Systematic Reviews Issue 4 2009
45. F.H. Messerli, S. Bangalore, and S. Julius Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension Circulation 117 2008 2706 2715 discussion 2715
46. D.S. Siscovick, T.E. Raghunathan, and B.M. Psaty Diuretic therapy for hypertension and the risk of primary cardiac arrest N Engl J Med 330 1994 1852 1857
47. M.E. Ernst, B.L. Carter, S. Zheng, and R.H. Grimm Jr Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium Am J Hypertens 23 2010 440 446
48. L.M. Wing, C.M. Reid, and P. Ryan A comparison of outcomes with angiotensin-convertingenzyme inhibitors and diuretics for hypertension in the elderly N Engl J Med 348 2003 583 592
49. Multiple Risk Factor Intervention Trial Research Group Multiple Risk Factor Intervention Trial Risk factor changes and mortality results JAMA 248 1982 1465 1477
50. Multiple Risk Factor Intervention Trial Research Group Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial Circulation 82 1990 1616 1628
51. K. Jamerson, M.A. Weber, and G.L. Bakris Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med 359 2008 2417 2428
52. D.L. Clement, M.L. De Buyzere, and D.A. De Bacquer Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension N Engl J Med 348 2003 2407 2415
53. J.H. Laragh, and J.E. Sealey Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT Am J Hypertens 16 2003 407 415